| Name | Title | Contact Details |
|---|
Biotronik is a leader in cardio- and endovascular medical technology (pacemakers, implantable defibrillators, stents and remote patient management). We put our heart in it. From its headquarters in Berlin, Germany, BIOTRONIK operates in more than 100 countries around the world, offering products and services essential to the lives of people living with cardiac conditions. BIOTRONIK employs highly committed employees who undertake tenacious research and development and meticulous manufacturing to meet this huge responsibility. BIOTRONIK´s products are designed, produced and sold by people who put their hearts into their work. Quality in every detail. From the very start, BIOTRONIK dedicated itself to driving progress and innovation and delivering exceptional quality. We have earned the trust of medical professionals and patients by combining the renowned art of German engineering with technical excellence and uncompromising quality standards. This dedication is evident in everything we do. High achievers are welcome. Medical engineering is an industry of the future. In a field marked by rapid developments and short innovation cycles, the best guarantees for sustainable success are committed, creative, team-oriented specialists, and outstanding leadership. If you are passionate about computer science, engineering or the natural sciences and enjoy developing new ideas, you´ve found the right place.
Activation Laboratories Ltd. is a Ancaster, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
VENTLAB CORP. is a Mocksville, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Bruder Healthcare is a Alpharetta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
With more than a 60-year history of pioneering products to treat millions of patients, Cordis is a worldwide leader in the development and manufacturing of interventional cardiovascular technology. Cordis established a legacy of high-quality and minimally-invasive cardiovascular products; and has built a robust global footprint with operations in more than 60 countries around the world. As from August 2, 2021, Cordis is a standalone company, and is committed to investing $300 million to accelerate innovation in its broad product portfolio. Building on our storied brand, we are unleashing our potential to be a $10 billion leader bringing new technology to the market through bold action at speed.